Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0028
-0.0012 (-30.00%)
At close: Jul 2, 2025
MYCOF Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
172.92K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Mydecine Innovations Group News
- 10 days ago - Mydecine Innovations Group Provides Update On Annual Financial Statements - TheNewswire
- 24 days ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 5 weeks ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 7 weeks ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 2 months ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 3 months ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Announces Director Resignation - GlobeNewsWire